paraj has outperformed Thyrocare.Posted a month back on listing day to Buy Parag,Sell Thyrocare on listing day.We stand vindicated.Lot of noise was made on forum because there was consensus building on thyrocare as next multi bagger while parag was seen as a failed company,but one must use common sense while investing.Parag is into diary business which has strong entry barrier,strong moat n margins are very attractive,its also market leader in few segments,commands respect next to Amul. while Thyocare is an unknown entity,shady promoters,weak moat,entry barrier easy anyone can replicate business,disruptive sector,DIY kits,pops n moms testing labs mushrooming all over.
Nibble a bit in Parag,strong MOAT,good business model,We have had given buy call ( in small quantities) in this counter, any panic sell off, must be bought into.This stock will give much better returns in long run than THYROCARE.
STRONG MOAT, difficult to replicate the diary business,trust is key factor here. After Amul, Parag has second highest market share in many diary segments.
On listing day every one says book profit & getout yourself. Icannot understand how we can take post listing benfit like ujjewen.can anybody guide to common investor